A new editorial was published in , Volume 16, on April 4, 2025, titled "Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques." ...

Castleman disease is an idiopathic, rare lymphoproliferative disorder. It is classified as multicentric Castleman disease, ...

New research shows heavy alcohol drinking can damage the brain, affect memory, shorten life span, thinking, focus, and ...

Heavy drinkers had a 133% higher chance of having brain lesions compared with nondrinkers, a study found. A medical expert explains how much alcohol is too much.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

WEDNESDAY, April 9, 2025 (HealthDay News) -- An experimental drug can help patients with advanced multiple sclerosis (MS) ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and onl ...